The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression. Spravato was ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

The treatment, known as 12 SQ-HDM SLIT, will help with the allergy which can be debilitating and cause facial swelling, ...

The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...

To reduce the risk of miscarriage and having babies with birth defects, maternal health experts have said pregnant women ...

But there are specific kinds that are best: “Cough medicines that contain guaifenesin and dextromethorphan should be okay for a short time,” says Meleen Chuang, MD, the chief of obstetrics and ...

These include underlying thyroid and heart conditions, as well as cold-related conditions such as frostbite or Raynaud's syndrome. Some researchers have found evidence of a relationship between a cold ...